Hyper- and dyslipidemia contribute to cardiovascular morbidity and mortality in diabetic patients. Pharmacological therapy to lower LDL cholesterol has convincingly shown to reduce cardiovascular risk in diabetic patients. The present article represents the recommendations of the Austrian Diabetes Association for the use of lipid-lowering drugs in diabetic patients according to current scientific evidence.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/s00508-019-1444-2 | DOI Listing |
Publication Analysis
Top Keywords
diabetic patients
12
[lipids-diagnosis therapy
4
therapy diabetes
4
diabetes mellitus
4
mellitus update
4
update 2019]
4
2019] hyper-
4
hyper- dyslipidemia
4
dyslipidemia contribute
4
contribute cardiovascular
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!